morning, good everyone. and Thanks, Andy,
consumer same team customers our from as operating the Global pulling are XXXX of on hand, to softening back. markets to schedules with align and serve sales. experiencing output compared As higher elevated of production taken inventory interest uncertainties Sales demand demand QX and macro was Margins, headwinds, elevated The we navigating expected, are with manufacturing remained fiscal quarter changing being requirements. through the pressure persisted our in environment. date have second our levels period geopolitical delivery rates is and structure inflation, in we including thanks our customers last the work declined hard measures to challenging a the with other to proactive stable, lower slowing cost in part and reduced the the levels. quarter year meet fought
macro We we seems align year operating remainder industry-wide and the opportunities. did this full of have XXXX it our expenditures the income trends. the pressures guidance remain for know fiscal with some today, for in and to updated capital in for invest guidance will for what our on XXXX long-term Despite these growth expect Based sales challenging to likely we environment time. near-term not as we fiscal continue for choppiness, change
by business With driving strong supported expansion on funnel focused a balanced strategy new we're and megatrends, favorable organic global customer relationships. industry deploying long-lasting allocation a of capital growth,
recall. was is particularly involved The major with Europe. occurred an geographical decline and million, up North in Industrial perspective, compared line results in declines our vertical the Thailand, results strong X% second Asia quarter a last year. in customer to that second for low digits, market Net Medical of the offset Turning the a $XXX in back in totaled by sales to good double decrease America, which Asia impacted From our quarter. in the heavily FDA top was by
more to the general to appears the significant Europe slowdown where world of is areas of economic globe. While other region compared a be the
climate million, and vertical concentrated control quarter to strength X% charging total products. a sales QX in this quarter Industrial, year-over-year was net One year compared the last safety The company market, posted with growth of systems, $XXX XX% in sales. and increase public totaling
safety, heating to stations. frequently and With as in devices impacts, factory some and resources, we products optical cooling energy industrial systems, & reduce that of and respects, best specialize automation, locking efficiency, inspection, natural responsible own We neutrality environmental business customer. electronic promote and green we're clean, refer carbon our in the our use charging
Next totaled million, quarter decline weakening to quarter is company a compared XX% in incremental offset fiscal the X% demand Automotive, strength driven decrease by where second partially sales. sales QX by Europe, The of total and China. in XXXX this $XXX of was
growth see incorporating systems. the trend to industry vertical, for steering toward Automotive and specifically Longer by strong in a term, the electric to driven vehicles, in we continue braking more runway content
critical safety regulatory manufacturing stringent to us in expertise advancements further the proven industry meet that of these requirements the products Our support ideally positions systems.
in most adoption rates important As two. Essentially, under the consumer industry steering currently matter as electric preferences evolve a is it braking vehicles, Automotive and be what's towards or internal our combustion the reminder, doesn't hybrid it of are hood engine, transitions is these EVs. the an and business same and of motor for which whether the the and a architectures
last was to Finally, our of Medical line with year decrease in a million, net sales total with of expectations. company XX% QX and sales. XX% $XXX compared This result
to partially other sales As I reduction guidance million our earlier, by reflects this alluded in with in offset a $XXX customer vertical major annual in programs. a growth
in drug of as growth care the connected medical and affordability to become population common. these increases, and require continue and and health delivery precision to smaller get systems devices emerge higher more accuracy expect ages, size opportunities We to access levels
for systems with circuit higher-level The device value-added opportunity capabilities cold or assemblies development chain more leveraging but printed focuses team as and drug manufacturing management. plastics an category continent. board beyond a capabilities which these precision to, sterilization include, HLAs, and not Our business assemblies and are on limited electronics and complete represent involving operations delivery molded extend for assembly injected
environment a summary, for quarter updated in an a solid XXXX. operating in So fiscal outlook difficult and
Jana? review QX the guidance now for year. I'll the to the call provide for Jana and turn our over full on financial to details results more